Serum CC16 is a potential predictor for IPF diagnosis and prognosis

Y. Tian (Nanjing, China), X. Gui (Nanjing, China), H. Li (Nanjing, China), J. Ding (Nanjing, China), Y. Liu (Nanjing, China), Y. Wang (Nanjing, China), J. Dai (Nanjing, China), H. Cai (Nanjing, China)

Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis
Session: Prognosis and biomarkers of idiopathic pulmonary fibrosis
Session type: E-poster session
Number: 816

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Y. Tian (Nanjing, China), X. Gui (Nanjing, China), H. Li (Nanjing, China), J. Ding (Nanjing, China), Y. Liu (Nanjing, China), Y. Wang (Nanjing, China), J. Dai (Nanjing, China), H. Cai (Nanjing, China). Serum CC16 is a potential predictor for IPF diagnosis and prognosis. 816

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: